Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Nature·2026

Same author

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Nature·2026

Same author

Engineering drug-responsive replication machinery for precise control of self-amplifying RNA.

Nature biomedical engineering·2026

Same author

Rapid boosting increases germinal center responses to sequential vaccines.

Nature immunology·2026

Same author

Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery to lymph nodes enhance humoral immune responses.

bioRxiv : the preprint server for biology·2026

Same author

Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecoviruses.

Cell reports·2026

Search research articles

Related Experiment Video

Updated: May 3, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

Structure-based programming of lymph-node targeting in molecular vaccines.

Haipeng Liu¹, Kelly D Moynihan², Yiran Zheng²

¹1] Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [2] Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [3] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

|February 18, 2014

Summary

This summary is machine-generated.

Researchers developed novel amphiphile vaccines (amph-vaccines) that leverage albumin binding to enhance lymph node targeting. This strategy significantly boosts T-cell priming and anti-tumor efficacy while reducing systemic toxicity for improved cancer vaccines.

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 3, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Area of Science:

Biotechnology
Immunology
Vaccine Development

Background:

Sentinel lymph nodes (LNs) are crucial for cancer staging and immune responses.
Current methods for LN identification in cancer patients utilize albumin-binding dyes.
This approach targets compounds to LNs for efficient filtration by phagocytes.

Purpose of the Study:

To translate the 'albumin hitchhiking' concept to molecular vaccines.
To develop amphiphile-based vaccines (amph-vaccines) for improved vaccine delivery and efficacy.
To enhance T-cell priming and anti-tumor responses while minimizing systemic toxicity.

Main Methods:

Synthesis of amphiphiles comprising antigen/adjuvant cargo, an albumin-binding tail, and a polar polymer chain.
Administration of structurally optimized CpG-DNA/peptide amph-vaccines in a mouse model.
Evaluation of LN accumulation, systemic dissemination, T-cell priming, anti-tumor efficacy, and toxicity.

Main Results:

Amph-vaccines demonstrated increased LN accumulation and reduced systemic dissemination compared to parent compounds.
A 30-fold increase in T-cell priming was observed with amph-vaccine administration.
Enhanced anti-tumor efficacy and significantly reduced systemic toxicity were achieved.

Conclusions:

Amph-vaccines offer a broadly applicable strategy for enhancing subunit vaccine potency and safety.
The 'albumin hitchhiking' approach effectively targets vaccine components to lymph nodes.
This novel vaccine platform holds promise for improved cancer immunotherapy.